Fetal rat kidney cells produce high levels of glial-derived neurotrophic factor (GDNF) and exert neuroprotective effects when transplanted into the brain in animal models of Parkinson's disease and stroke. The purpose of the present experiment was to produce kidney cell lines that secrete GDNF. Genes encoding two truncated N-terminal fragments of SV40 large T antigen, T155g and T155c, which does not code for small t antigen, were used. T155g was transduced into E17 cultured fetal Sprague-Dawley rat kidney cortex cells using a plasmid vector, and T155c was transduced with a plasmid and a retroviral vector. Sixteen clones were isolated from cultures transfected with the T155g-expressing plasmid. No cell lines were obtained with T155c. Four clones produced GDNF at physiological concentrations ranging from 55 to 93 pg/ml of medium. These four clones were transplanted into the ischemic core or penumbra of rats that had undergone middle cerebral artery occlusion (MCAO). Three of the four clones reduced the volume of infarction and the behavioral abnormalities normally resulting from MCAO. Blocking experiments with antibodies to GDNF and platelet-derived growth factor (PDGF) suggested that these growth factors contributed only minimally to the reduction in infarct volume and behavioral abnormality. These cell lines may be useful for intracerebral transplantation in animal models of brain injury, stroke, or Parkinson's disease.
INTRODUCTION
brally. The fetal kidney cortex represents a particularly good source of GDNF-producing cells (13,16,28). Granholm and colleagues (15) cografted parkinsonian ani-There is a large body of evidence suggesting that glial cell line-derived neurotrophic factor (GDNF) can mals with fetal ventral mesencephalic (VM) tissue and fetal kidney tissue. Rats with cografts had significantly enhance the survival and growth of neurons under a variety of conditions. Although GDNF plays a particularly better outcomes in a Parkinson's disease model, as measured both behaviorally and histologically, than animals important role in the development and survival of dopaminergic neurons (23) , the development and survival of with VM grafts alone. The improved outcome was attributed to the production of GDNF by the kidney cell other neuronal cell types are also affected by GDNF. In animal models of stroke, GDNF can reduce the effects cografts. Likewise, Chiang et al. (9) , using a rat model of stroke, transplanted fetal kidney cells into the ische-of middle cerebral artery occlusion when administered intracerebroventricularly or intraparenchymally (18, 36) , mic core and found that intracortical transplants of fetal kidney tissue protected the cortex from subsequent mid-or using an adenovirus (19) (20) (21) , and can protect hippocampal neurons after forebrain ischemia (26) . It is con-dle cerebral artery occlusion, as assessed behaviorally and histologically. The authors concluded that the smaller ceivable that GDNF could also potentially be applied as a therapy or adjunct therapy in a number of other CNS infarction volume was probably due to the diffusion of some factor or factors from the kidney cells, most likely diseases that affect humans.
One problem with the use of GDNF in a clinical set-GDNF.
The use of primary cells for transplantation, while ting is its delivery into the brain. The transplantation of GDNF-producing cells represents one means of provid-theoretically possible, would also be accompanied by a range of problems, such as the difficulty in finding a ing specifically targeted delivery of GDNF intracere-suitable donor, the variability of the tissue, and the ne-responsible for the effects seen on behavioral and histological outcomes. cessity of having to repeatedly test the tissue for viability, homogeneity, and infectious agents. On the other hand, if a cell line was available for such use, these METHODS problems would be overcome and there would be a con-
In Vitro Experiments tinuous supply of homogeneous and defined cells. For
Construction of T155g and T155c. The construction example, Johnston and colleagues (17) transplanted two of T155g followed the procedure described previously commercially available GDNF-producing kidney cell (35). Briefly, a gene fragment consisting of the coding lines into the ischemic penumbra and successfully resequence for the first 155 amino acids of the T antigen duced both the volume of infarct and behavioral abnorwas generated by polymerase chain reaction (PCR) usmalities.
ing a plasmid containing the wild-type full-length geno-The term "cell line" implies immortalization, a process mic large T sequence (pCMV/SVE/neo) as a template. that differs for human and rodent cells (30) . Immortaliza-
The sequence was inserted into a pRc/RSV expression tion of most human somatic cells requires telomerase or vector (Invitrogen, Carlsbad, CA), which includes the an alternative mechanism for telomerase maintenance, Rous sarcoma virus LTR to drive expression. whereas at least some types of rodent cells can be main-T155g, derived from the genomic SV40 large T gene, tained indefinitely in culture simply by manipulation of encodes both large T and small t antigens. Two addithe culture conditions (25, 33) . Other cell types may retional vectors were constructed containing the cDNA of quire growth stimuli to maintain an immortal phenotype T155, called T155c, which eliminates the expression of (22) . Simian virus 40 (SV40) is known to increase the small t. One vector was the same pRc/RSV plasmid as rate at which both rodent and human cells become imwas used for T155g, and the other was a retroviral exmortal, in part by maintaining cells in the cell cycle.
pression vector system using the pLNCX vector (Retro-Two of the protein products of SV 40, large T antigen Xpress System, Clontech, Palo Alto, CA). Details will and small t antigen, can result in changes in the rate of be reported elsewhere. cell proliferation and/or induce a transformed phenotype. Large T antigen has well-described effects on both Cell Culture and Transfection of T155c and T155g. Fetal kidney cortex cells were harvested from E17 Rb and p53, in addition to several other cellular proteins including Hsc70 and p300 (10,31). One mechanism by Sprague-Dawley rats and were mechanically dissociated via repeated passaging through a glass pipette. The cells which cell growth is influenced by SV40 T antigen involves binding to the nonphosphorylated form of Rb, were plated into a 75-cm 2 flask and maintained in a 5% CO 2 incubator in Dulbecco's modified Eagle's medium resulting in an increase in unbound E2F, which is then free to induce entry into the S phase of the cell cycle (32).
(DMEM)/F12 containing 10% fetal calf serum (complete medium). Cells were grown to confluence, split Although it is known that expression of SV40 large T antigen is capable of immortalizing cells, the cells thus into three separate 75-cm flasks, and transfected at 80% confluence. Separate flasks of cells were treated with produced usually have undifferentiated phenotypes. In fact, large T antigen interferes with many normal cellu-T155g/plasmid, T155c/plasmid, and T155c/retrovirus. Cells treated with the T155g/plasmid or T155c/plasmid lar functions [reviewed in (8, 35) ]. In an attempt to further characterize the necessary conditions for immortali-were transfected using the FuGENE 6 reagent (Roche Molecular Biochemicals, Indianapolis, IN). A transfec-zation, and to maximize the retention of normal cellular function and phenotype, we have developed two trun-tion reagent/DNA ratio of 6:1 was used with the DNA concentration of 1.2-2 µg/µl DNA. The serum-free me-cated N-terminal fragments of SV40 large T antigen, T155g (genomic) and T155c (cDNA). In both cases, the dium/FuGENE 6/plasmid mix was added to the cells. For infection of cells using T155c/retrovirus, medium p53 binding domain has been removed, both to facilitate normal phenotypic development and to decrease the ten-was replaced by filtered conditioned medium generated by producer cells secreting the virus and incubated over-dency of SV40 large T antigen to promote the survival of cells with mutations or karyotypic abnormalities (35).
night. Two days after transfection or infection, cells expressing the transgene were selected by exposure to 500 One aim of the present experiment was to determine whether it is possible to obtain GDNF-producing cell µg/ml G418 (geneticin) for approximately 2 weeks, until almost all cells had died. The medium was replaced, and lines by transfecting either T155c or T155g into fetal kidney cortical cells. The second aim was to test some single cells that developed into colonies of surviving cells were identified. Sixteen colonies of cells were of the resulting cell lines in vivo for their effectiveness in alleviating the effects of ischemia in a rat model of transferred into 25-cm 2 flasks and grown in complete medium. Cell lines were named Rkt (rat kidney T155g-stroke. Third, we wanted to determine to what extent the growth factors released by the kidney cell lines were converted) 1 through 16. Complete medium was replaced by serum-free medium 3 days prior to ELISA experi-In Vivo Experiments ments (described below).
Animals. A total of 44 adult male Sprague-Dawley rats weighing more than 300 g were used in the in vivo ELISA Assays. Enzyme-linked immunosorbent assays experiments. All rats underwent middle cerebral artery (ELISAs) were carried out following procedures proocclusion (MCAo). Rats were assigned to 1 of 11 groups. vided by R & D Systems (Minneapolis, MN). Each well There were two main experiments conducted. In the first of a 96-well ELISA plate was coated with 4 µg/ml capexperiment (Transplant experiment), rats received transture antibody in phosphate-buffered saline (PBS) and inplants of kidney cell lines Rkt3, Rkt5, Rkt6, or Rkt11 cubated overnight. Plates were blocked with 1% BSA, into the ischemic core, or received an infusion of vehicle 5% sucrose, and 0.05% NaN 3 in PBS for 2 h. Condiinto the ischemic penumbra. This yielded five treatment tioned medium (100 µl) from the Rkt cultures or serial groups (n = 4). In the second experiment (Antibody exdilutions of recombinant human growth factor was periment), rats were assigned to one of six groups: two added to wells, and samples were incubated for 3 h at groups received transplants of Rkt5, one with a simultaroom temperature. Detection of bound growth factor neous infusion of GDNF antibody, the other with simulwas achieved using 200 ng/ml detection antibody intaneous infusion of PDGF antibody (Rkt5 anti-GDNF cubated overnight at 4°C, followed by incubation in and Rkt5 anti-PDGF, respectively). Similarly, two groups 1/20,000 of a 1.25 mg/ml solution of streptavidin horsereceived transplants of Rkt6, one with GDNF antibody radish peroxidase. Each well was then incubated in a 1:1 and the other with PDGF antibody (Rkt6 anti-GDNF mixture of color A reagent and color B reagent (R & D and Rkt6 anti-PDGF). Two control groups received in-Systems) for 20 min at room temperature, after which 1 fusions of GDNF or PDGF antibody alone (anti-GDNF M H 2 SO 4 was added. Optical density was measured at and anti-PDGF). This yielded six treatment groups (n = 450 nm with wavelength correction set at 540 nm. All 4). MCAo, transplantation, and antibody infusion are deantibodies and recombinant growth factors were supscribed in more detail below. plied by R & D Systems.
The four cell lines whose conditioned medium con-Middle Cerebral Artery Occlusion. MCAo surgery tained the most GDNF (Rkt3, Rkt5, Rkt6, and Rkt11) was performed as described elsewhere (3,4,27). An emwere subject to further ELISA analyses for seven other bolic filament was inserted through the carotid artery to growth factors, these being platelet-derived growth facreach the junction of the MCA, resulting in the obstructor (PDGF), basic fibroblast growth factor (bFGF), tion of blood flow from the common carotid artery and transforming growth factors TGFβ1 and TGFβ2, brain the circle of Willis. Under deep anesthesia using chloral derived neurotrophic factor (BDNF), epidermal growth hydrate (400 mg/kg, IP), a ventral midline cervical incifactor (EGF), and ciliary neurotrophic factor (CNTF). sion was made and the right common carotid artery was identified and isolated. The embolus size was 4-0, made Histochemistry. The four cell lines producing the of sterile, nonabsorbable suture (Ethicon, Inc., Somermost GDNF were subject to further characterization by ville, NJ), with the diameter of the embolic tip tapered histochemical staining for SV40 large T, vimentin, fito 24-26-gauge size using rubber cement. In order to bronectin, ZO-1, cadherin, and keratin. In each case the block the MCA, about 15-17 mm of the embolic filasame general staining procedure was followed. Cells ment was inserted from the junction of the external and were fixed in 4% paraformaldehyde in PBS for 7 min at internal carotid arteries. The right MCA was occluded room temperature, permeabilized with ethanol/acetic for 1 h. Based on our studies and several others (3,4,6, acid solution (95%/5%) at −20°C for 1-2 min, then 27), a 1-h occlusion of the MCA results in maximal inblocked with 10% horse serum in Tris-buffered saline.
farction. In addition, the length and size of the tip of the The following primary antibodies were prepared at 1:100 embolus have been found to produce complete MCA ocin TBS with 1% horse serum: mouse anti-SV40 large clusion in animals weighing between 250 and 350 g (6). T (Calbiochem, San Diego, CA); mouse anti-vimentin (Sigma, St. Louis, MO); rabbit anti-fibronectin (Sigma);
Transplantation. Rats received transplants during the occlusion phase of the ischemia procedure. Each rat re-rabbit anti-ZO-1 (Zymed, San Francisco, CA); mouse anti-cadherin (Sigma), and mouse anti-keratin (Zymed).
ceived a transplant of 80,000 viable cells, as identified by the trypan blue exclusion method, into the ischemic Cells were incubated with primary antibody overnight at 4°C. Secondary antibody (Molecular Probes, Tempe, AZ) penumbra according to the experimental design described above. Two groups of control rats received infu-was conjugated to FITC for use with rabbit antibodies and Alexa Red for use with mouse antibodies. Cells were sions of vehicle: one group into the ischemic core, the other into the ischemic penumbra. The cells were sus-incubated with secondary antibody at 1:100 for 1 h at room temperature and were visualized under a Zeiss micro-pended in PBS and 3 µl of cell suspension was infused intraparenchymally at a rate of 1 µl/min. Stereotaxic in-scope using appropriate filters for use with fluorescence. jections of cells were performed using a 10-µl Hamilton mm-thick sections. The brain slices were incubated in 2% TTC dissolved in PBS for 30 min at 37°C and then microsyringe fitted with steel cannula (inner diameter = 0.25 mm, outer diameter = 0.47 mm). The ischemic core transferred to 5% formaldehyde solution for fixation. Infarction is revealed by a lack of TTC staining, which has previously been found to be localized within the lateral aspect of the striatum (3,4,6). The penumbra, the indicates that tissue is dehydrogenase deficient. The volume of infarction was measured in each slice and immediate area next to this core and identified by increased glial activation, includes the medial aspect of summed using computerized planimetry (PC-based Image Tools software). The volume of infarction was cal-the striatum (7). Ischemic penumbra transplants were placed at the following coordinates: AP: +1.2 mm; ML: culated as 2 mm (thickness of the slice) × [sum of the infarction area in all brain slices (mm 2 )] (9,34). 1.8 mm; DV: −5.0 mm (29) .
Antibody Infusion. Within 5 min of retracting the
Statistical Analyses. For both the Transplant and Ancannula used for transplantation, a steel cannula (inner tibody experiments, separate ANOVAs were performed diameter = 0.25 mm, outer diameter = 0.47 mm) was inon infarct volume and EBST data, and multiple pairwise troduced into the transplant site. Antibodies were incomparisons were made. To correct for inflated alpha fused at 1 µl/min for 3 min. Concentrations of antibodies resulting from multiple pairwise comparisons, results were those recommended by R & D Systems to achieve were interpreted using the Bonferroni correction, such neutralization: 3 µg/ml for anti-GDNF and 10 ng/ml for that p values were not significant unless less than 0.005 anti-PDGF. The infusion cannula was left in place for 5 for the Transplant experiment, and less than 0.0033 for min following antibody infusion to minimize backflow the Antibody experiment. of solution along the cannula track. There were no overt behavioral effects following infusion of the antibody so-RESULTS lutions, nor were there any significant changes in weight ELISA Assays over the 3-day test period.
Sixteen clones were isolated following transfection Elevated Body Swing Test. The behavioral consewith the T155g construct, whereas no clones were proquences of MCAo/transplantation/antibody were tested duced by T155c using either the plasmid or retroviral at 3 days following reperfusion using the elevated body constructs. Of the 16 clones identified, four were found swing test (EBST), which has been described and used to produce detectable physiological concentrations of previously (5,17). The EBST is a measure of motor GDNF, these being Rkt3, Rkt5, Rkt6, amd Rkt11. Conasymmetry that has been used to characterize a stable centrations of GDNF in conditioned medium were as motor asymmetry in rats with successful occlusion of follows: Rkt3: 55 pg/ml; Rkt5: 90 pg/ml; Rkt6: 93 pg/ml; the MCA as early as 24 h after MCAo (1,2,14). Ischemic Rkt11: 82 pg/ml. GDNF was not detected in the condianimals display greater than 75% bias in swing direction tioned medium of the other 12 clones. as early as 24 h postischemia surgery, extending up to 6
Conditioned medium from these four cell lines was months (3-6,9,34). The direction of the swing bias is then subjected to further ELISA analyses to determine dependent upon the location of the ischemia, where ipsithe concentrations of PDGF, TGFβ1, TGFβ2, bFGF, lateral (to the infracted side) responses result from local-BDNF, CNTF, and EGF. There was no CNTF or EGF ized striatal damage. To assess elevated body swing, the in the conditioned medium of these cell lines. The other animal is tested inside a clear Plexiglas box (40 × 40 × five growth factors were present in conditioned medium 35.5 cm). The animal is gently picked up by the base of in various amounts (Table 1) . its tail until its nose is 5 cm above the floor of the test box. When the animal's head moves sideways approximately 10°from the midline position of the body, the direction of the swing (left or right) is recorded, and the hydrate, 500 mg/kg, IP). The brain was then removed, immersed in cold saline for 5 min, and sliced into 2.0-Results are shown as mean pg/ml with SEM in parentheses.
Cell Characterization
The same four cell lines (Rkt3, Rkt5, Rkt6, and Rkt11) were further characterized by histochemical staining for SV40 large T, vimentin, fibronectin, ZO-1, cadherin, and keratin. Cells from all four lines stained positive for SV40 large T, vimentin, fibronectin, and ZO-1, but were negative for cadherin and keratin (results not shown). Cells doubled approximately every 24 h and underwent eight passages before ELISA analysis.
Transplant Experiment
An ANOVA revealed a significant effect of group on infarct volume, F(4, 15) = 87.79, p < 0.0001, where groups receiving cell lines Rkt3, Rkt5, and Rkt11 had significantly smaller infarct volumes than the group receiving vehicle treatment (p < 0.0001 in each case). However, the group receiving Rkt6 had an infarct volume that was not significantly different from the vehicle-treated group (Fig. 1) .
A separate ANOVA revealed a significant effect of group on EBST, F(4, 15) = 32.938, p < 0.0001. Groups receiving cell lines Rkt3, Rkt5, and Rkt11 had signifi- receiving Rkt6 had an EBST score not significantly difwhile treatment with Rkt6 had no effect. **p < 0.0001. ferent from the vehicle-treated group (Fig. 2) .
Several statistical analyses (not shown) were performed to attempt to determine whether there was any relationship between the concentrations of growth factors in conditioned medium and the outcome on either infarct volume or EBST. Correlation, regression, and factor analyses revealed no significant association between amounts of any single growth factor or combination of growth factors produced by the cells with either of the outcome measures. Because of this apparent lack of association, the antibody experiment was performed to further determine the nature and extent of any relationship between the growth factors assayed in conditioned medium and the outcomes measured. The Transplantation experiment revealed that Rkt6 was unambiguously the worst cell line in terms of its ability to reduce infarct volume or behavioral abnormality following MCAo. Rkt5 was nominally the bestperforming cell line on both measures, although the outcomes of rats treated with this cell line did not differ significantly from those of rats treated with Rkt11. To simplify further investigations into the mechanisms used by these cell lines in improving the outcome following MCAo, only cell lines Rkt5 and Rkt6 were used in subsequent studies. To determine the effects of antibodies on the outin infarct volume relative to vehicle (p < 0.0001), while treatment with Rkt6 had no effect. **p < 0.0001. come measures, data were considered in two parts: the effect of anti-GDNF treatment, and the effect of anti-PDGF treatment. In each case, data from the transplantation experiment for Rkt5, Rkt6, and vehicle treatment were used for statistical analysis and comparison. Comparisons were not considered statistically significant unless p < 0.0033.
Anti-GDNF. For anti-GDNF, an ANOVA revealed a significant effect of group on infarct volume, F(5, 18) = 81.719, p < 0.0001. Treatment with anti-GDNF significantly increased infarct volume in animals treated with Rkt5 (Rkt5 vs. Rkt5 anti-GDNF, p < 0.0033). On the other hand, treatment with anti-GDNF significantly decreased infarct volume in animals treated with Rkt6 (Rkt6 vs. Rkt6 anti-GDNF, p < 0.0001). Treatment with anti-GDNF alone led to a significantly larger infarct volume than treatment with vehicle (p < 0.0033) (Fig. 3) .
A separate ANOVA revealed a significant effect of group on EBST, F(5, 18) = 23.247, p < 0.0001. However, treatment with anti-GDNF had no significant effect on EBST for animals treated with either Rkt5 or Rkt6, nor did treatment with anti-GDNF alone have any significant effect on EBST relative to treatment with vehi- (Fig. 4) . Rkt6 . Treatment with anti-GDNF had no significant effect on EBST in animals receiving either Rkt5 or Rkt6.
Anti-PDGF. For anti-PDGF, an ANOVA revealed a significant effect of group on infarct volume, F(5, 18) = 89.522, p < 0.0001. Treatment with anti-PDGF had no significant effect on infarct volume in animals treated with Rkt5. On the other hand, treatment with anti-PDGF significantly decreased infarct volume in animals treated with Rkt6 (Rkt6 vs. Rkt6 anti-PDGF, p < 0.0001). Treatment with anti-PDGF alone did not have any significant effect on infarct volume relative to treatment with vehicle (p < 0.0033) (Fig. 5) .
A separate ANOVA revealed a significant effect of group on EBST, F(5, 18) = 27.023, p < 0.0001. Treatment with anti-PDGF had no significant effect on EBST for animals treated with Rkt5, but anti-PDGF significantly reduced EBST scores for animals treated with Rkt6 (Rkt6 vs. Rkt6-anti-PDGF, p < 0.0033). Treatment with anti-PDGF alone did not lead to a significantly different EBST score than treatment with vehicle ( Fig. 6 ). The present study examined immortalization of rat with anti-GDNF significantly increased infarct volume in anikidney cells using a technique developed in this laboramals receiving Rkt5 (p < 0.0033), but decreased infarct voltory and the use of these immortalized cells in reducing ume in animals receiving Rkt6 (p < 0.0001). Treatment with the adverse consequences of MCAo stroke model in rats.
DISCUSSION

anti-GDNF alone led to a significantly greater infarct volume
We demonstrated that T155g, a truncated version of the than treatment with vehicle alone (p < 0.0033). *p < 0.0033; **p < 0.0001. SV40 large T antigen, can be used to immortalize kid-ney cells. Moreover, these cells maintain at least some of their original function, in the form of producing GDNF and other growth factors. It is interesting to note that T155c, which does not code for small t antigen, did not generate any cell lines while T155g, which does code for small t antigen, was able to generate clones. However, it would be premature to suggest small t antigen is necessary to achieve cellular immortalization of primary rat fetal kidney cells, as we did not demonstrate that transfection rates, integration rates, and expression levels were similar for T155c and T155g.
Four clones were produced, which we hypothesized would reduce infarct volume and behavioral abnormality following ischemia on the basis of GDNF production. Indeed, three of the four clones did improve outcome on both measures, but one clone, Rkt6, did not reduce infarct volume or EBST score. Further investigation of the relationship between the cell lines and the growth factors they produced in vitro provided no explanation for the observation that Rkt5 was best able to reduce infarct volume and EBST, while Rkt6 was least able to do either. Statistical analyses revealed that growth factor pro- Figure 6 . Effect of antibody to PDGF on elevated body swing duction, at least as measured in vitro, was not a predictor test after intracerebral transplantation of either Rkt5 or Rkt6. Treatment with anti-PDGF had no effect on EBST in animals of outcome. This conclusion was confirmed by the antireceiving Rkt5, but decreased EBST in animals receiving Rkt6 (p < 0.0033). Treatment with anti-PDGF alone had no effect on EBST relative to treatment with vehicle. body experiments, in which it was shown that although anti-GDNF antibody significantly attenuated the ability of Rkt5 to reduce infarct volume, the antibody did not completely eliminate the effect of Rkt5 on infarct volume. Moreover, anti-GDNF had no effect on the reduction in EBST scores by Rkt5. Even more clearly, anti-PDGF antibody had no effect on the ability of Rkt5 to reduce infarct volume or EBST. Taken together, these results suggest that GDNF was only slightly responsible, and PDGF not at all, for the ability of Rkt5 to improve outcome when transplanted after MCAo. The general lack of effect of the antibodies was not likely due to poor methodology or low activity of the antibodies, because the infusion of anti-GDNF into the brains of vehicle-treated animals significantly increased the volume of infarct relative to vehicle treatment alone. This effect was most likely due to the blockage by anti-GDNF of endogenous GDNF upregulated in the host brain as a response to infarction.
Although it appears that the growth factors, as re- is not known what factor(s) was responsible for the abilceiving Rkt6 (p < 0.0001). Treatment with anti-PDGF alone ity of Rkt5 to improve both outcome measures, nor why had no effect on infarct volume relative to treatment with vehicle. **p < 0.0001.
Rkt6 was ineffective. It is interesting to note that block- 
